The Designer Drug αPHP Affected Cell Proliferation and Triggered Deathly Mechanisms in Murine Neural Stem/Progenitor Cells.

CNS toxicity cell death pathways mitochondrial toxin neural stem/progenitor cells new psychoactive substances synthetic cathinones ultrastructural damage αPHP

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
11 Sep 2023
Historique:
received: 30 06 2023
revised: 08 08 2023
accepted: 07 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Increasing reports of neurological and psychiatric outcomes due to psychostimulant synthetic cathinones (SCs) have recently raised public concern. However, the understanding of neurotoxic mechanisms is still lacking, particularly for the under-investigated αPHP, one of the major MDPV derivatives. In particular, its effects on neural stem/progenitor cell cultures (NSPCs) are still unexplored. Therefore, in the current in vitro study, the effects of increasing αPHP concentrations (25-2000 μM), on cell viability/proliferation, morphology/ultrastructure, genotoxicity and cell death pathways, have been evaluated after exposure in murine NSPCs, using a battery of complementary techniques, i.e., MTT and clonogenic assay, flow cytometry, immunocytochemistry, TEM, and patch clamp. We revealed that αPHP was able to induce a dose-dependent significant decrease of the viability, proliferation and clonal capability of the NSPCs, paralleled by the resting membrane potential depolarization and apoptotic/autophagic/necroptotic pathway activation. Moreover, ultrastructural alterations were clearly observed. Overall, our current findings demonstrate that αPHP, damaging NSPCs and the morpho-functional fundamental units of adult neurogenic niches may affect neurogenesis, possibly triggering long-lasting, irreversible CNS damage. The present investigation could pave the way for a broadened understanding of SCs toxicology, needed to establish an appropriate treatment for NPS and the potential consequences for public health.

Identifiants

pubmed: 37759624
pii: biology12091225
doi: 10.3390/biology12091225
pmc: PMC10525791
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Cell Biol. 2022 Jun 6;221(6):
pubmed: 35551578
J Cancer Surviv. 2017 Dec;11(6):704-719
pubmed: 28779220
Life Sci. 2014 Feb 27;97(1):2-8
pubmed: 23911668
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Feb 11;1193:123162
pubmed: 35180546
Cell Stem Cell. 2015 Oct 1;17(4):385-95
pubmed: 26431181
Toxicol Lett. 2020 Oct 1;331:42-52
pubmed: 32464236
ACS Omega. 2020 Jul 06;5(28):17223-17231
pubmed: 32715208
PLoS One. 2008 Feb 13;3(2):e1604
pubmed: 18270591
Int J Mol Sci. 2017 Nov 11;18(11):
pubmed: 29137119
Toxicol In Vitro. 2012 Oct;26(7):1075-86
pubmed: 22735693
J Biol Chem. 2011 Nov 4;286(44):38592-38601
pubmed: 21900249
F1000Res. 2014 Jan 22;3:21
pubmed: 25352977
J Cell Biol. 2003 Jan 6;160(1):65-75
pubmed: 12515825
Front Neurosci. 2018 May 23;12:336
pubmed: 29875623
J Cell Sci. 2003 Feb 1;116(Pt 3):525-36
pubmed: 12508113
Toxicology. 2017 Jul 1;386:93-102
pubmed: 28578026
Methods Mol Biol. 2013;1078:9-21
pubmed: 23975817
J Pharmacol Exp Ther. 2011 Nov;339(2):530-6
pubmed: 21810934
Antioxid Redox Signal. 2011 Jun 15;14(12):2545-79
pubmed: 20868295
Int J Mol Sci. 2020 Feb 18;21(4):
pubmed: 32085614
BMC Biol. 2011 Jun 02;9:39
pubmed: 21635796
Sci Rep. 2019 Jul 12;9(1):10147
pubmed: 31300716
Exp Brain Res. 2014 Sep;232(9):2775-84
pubmed: 24770860
Int J Mol Sci. 2022 Mar 18;23(6):
pubmed: 35328703
Toxicol Appl Pharmacol. 2019 Feb 1;364:1-11
pubmed: 30529627
Hum Mol Genet. 2019 Jan 1;28(1):64-73
pubmed: 30239720
Methods Mol Biol. 2008;445:77-88
pubmed: 18425443
Front Neurosci. 2016 Apr 19;10:153
pubmed: 27147945
Neuropharmacology. 2018 May 15;134(Pt A):65-72
pubmed: 29030166
Subst Abuse Rehabil. 2014 May 26;5:37-52
pubmed: 24966713
Int J Mol Sci. 2019 Mar 28;20(7):
pubmed: 30925718
Eur Arch Psychiatry Clin Neurosci. 2007 Aug;257(5):261-70
pubmed: 17401727
Oncotarget. 2016 Jun 28;7(26):39544-39555
pubmed: 27250032
Front Cell Dev Biol. 2022 Feb 14;10:793328
pubmed: 35237597
Eur J Neurosci. 2002 Apr;15(8):1299-305
pubmed: 11994124
Science. 1992 Mar 27;255(5052):1707-10
pubmed: 1553558
Cell Mol Biol Lett. 2016 Dec 13;21:29
pubmed: 28536631
Cell Death Discov. 2021 Feb 17;7(1):34
pubmed: 33597506
Prostaglandins Other Lipid Mediat. 2016 Jan;122:54-63
pubmed: 26732541
Int J Mol Sci. 2020 Jul 09;21(14):
pubmed: 32660154
Brain Res Bull. 2016 Sep;126(Pt 1):61-67
pubmed: 26995278
Front Neurosci. 2021 Mar 22;15:589906
pubmed: 33828444
Medicines (Basel). 2022 Mar 01;9(3):
pubmed: 35323718
Dtsch Arztebl Int. 2014 Feb 28;111(9):139-47
pubmed: 24661585
Ther Drug Monit. 2021 Feb 1;43(1):52-68
pubmed: 32881779
Int J Mol Sci. 2021 Jul 09;22(14):
pubmed: 34299015
Anticancer Agents Med Chem. 2022;22(11):2048-2062
pubmed: 34825878
Mol Cell. 2022 Mar 3;82(5):933-949.e9
pubmed: 35120587
Front Pharmacol. 2020 Jan 28;10:1588
pubmed: 32063845
Int J Mol Sci. 2022 Dec 02;23(23):
pubmed: 36499528
Arch Toxicol. 2017 Nov;91(11):3663-3676
pubmed: 28527032
Cell Death Differ. 1999 Feb;6(2):99-104
pubmed: 10200555
J Pharmacol Exp Ther. 2017 Jan;360(1):33-47
pubmed: 27799294
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Transl Psychiatry. 2020 Sep 28;10(1):331
pubmed: 32989216
Neuron. 2011 May 26;70(4):687-702
pubmed: 21609825
EBioMedicine. 2018 Apr;30:29-37
pubmed: 29605508
J Neurochem. 2004 Jan;88(1):212-26
pubmed: 14675165
Methods Mol Biol. 2007;399:199-213
pubmed: 18309934
Methods Mol Biol. 2008;438:173-84
pubmed: 18369757
FEBS J. 2018 Feb;285(3):416-431
pubmed: 28755482
Oncotarget. 2017 May 2;8(33):54604-54615
pubmed: 28903368
J Med Toxicol. 2012 Mar;8(1):33-42
pubmed: 22108839
Int J Mol Sci. 2020 Dec 28;22(1):
pubmed: 33379373
Biochem Pharmacol. 2009 Jul 15;78(2):191-202
pubmed: 19442964
Methods Mol Biol. 2002;198:115-23
pubmed: 11951614
Cell Death Differ. 2012 Feb;19(2):245-56
pubmed: 21738214
Methods. 2018 Feb 1;134-135:56-66
pubmed: 29175336
Neurosci Lett. 2016 Aug 26;629:125-130
pubmed: 27320055
Methods Mol Biol. 2013;1078:23-33
pubmed: 23975818
J Mol Cell Biol. 2022 Jan 29;13(12):853-863
pubmed: 34562084
Psychopharmacology (Berl). 2019 Mar;236(3):1079-1095
pubmed: 30368582
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):529-31
pubmed: 10639111
Int J Mol Sci. 2021 Jun 12;22(12):
pubmed: 34204826
Neurotox Res. 2016 Aug;30(2):239-50
pubmed: 27295059
Forensic Sci Int. 2016 Aug;265:121-4
pubmed: 26890319
Forensic Sci Int. 2014 Oct;243:1-13
pubmed: 24769262
Cell Mol Life Sci. 2019 Jan;76(2):231-244
pubmed: 30306211
Arch Toxicol. 2015 May;89(5):757-71
pubmed: 24903018
FEBS Lett. 2000 Jul 7;476(3):118-23
pubmed: 10913597
J Membr Biol. 2006 Jan;209(1):43-58
pubmed: 16685600
Sci Rep. 2015 Oct 14;5:14924
pubmed: 26462443
Eur Neuropsychopharmacol. 2015 Mar;25(3):365-76
pubmed: 25624004
Can J Physiol Pharmacol. 2023 May 1;101(5):235-243
pubmed: 36821836
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Int J Mol Sci. 2020 Jul 16;21(14):
pubmed: 32708719
Curr Neuropharmacol. 2017;15(5):738-749
pubmed: 27908258
Cancers (Basel). 2022 Dec 15;14(24):
pubmed: 36551689
Neurotoxicology. 2019 Jul;73:8-16
pubmed: 30802466
Drug Test Anal. 2011 Jul-Aug;3(7-8):439-53
pubmed: 21755607
Arch Toxicol. 2019 Sep;93(9):2617-2634
pubmed: 31468101
ACS Chem Neurosci. 2017 Apr 19;8(4):850-859
pubmed: 28067045
J Hematother Stem Cell Res. 2003 Dec;12(6):655-70
pubmed: 14977475
Nat Rev Neurosci. 2015 Nov;16(11):647-59
pubmed: 26420377
Neuropharmacology. 2014 Apr;79:152-60
pubmed: 24275046
Neurotox Res. 2019 Jan;35(1):49-62
pubmed: 29934755
Int J Mol Sci. 2023 Mar 25;24(7):
pubmed: 37047201
Clin Toxicol (Phila). 2016 Aug;54(7):563-7
pubmed: 27227375
Arch Toxicol. 2021 Sep;95(9):2895-2940
pubmed: 34100120

Auteurs

Elisa Roda (E)

Laboratory of Clinical & Experimental Toxicology, Pavia Poison Centre, National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Fabrizio De Luca (F)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Erica Cecilia Priori (EC)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Daniela Ratto (D)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Silvana Pinelli (S)

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

Emilia Corradini (E)

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

Paola Mozzoni (P)

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

Diana Poli (D)

INAIL Research, Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Via Fontana Candida, 1, 00078 Monte Porzio Catone, Italy.

Giuliano Mazzini (G)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.
Institute of Molecular Genetics-CNR (National Research Council), 27100 Pavia, Italy.

Maria Grazia Bottone (MG)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Anna Maria Gatti (AM)

Laboratory of Clinical & Experimental Toxicology, Pavia Poison Centre, National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Matteo Marti (M)

Department of Translational Medicine, Section of Legal Medicine, LTTA Center and University Center of Gender Medicine, University of Ferrara, 44121 Ferrara, Italy.
Collaborative Centre for the Italian National Early Warning System, Department of Anti-Drug Policies, Presidency of the Council of Ministers, 44121 Ferrara, Italy.

Carlo Alessandro Locatelli (CA)

Laboratory of Clinical & Experimental Toxicology, Pavia Poison Centre, National Toxicology Information Centre, Toxicology Unit, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.

Paola Rossi (P)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, 27100 Pavia, Italy.

Daniele Bottai (D)

Department of Pharmaceutical Sciences, Section of Pharmacology and Biosciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.

Classifications MeSH